1-3 of 3
Amy McGranahan
Close
Sort by
Journal Articles

Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia

Rachel M. A. Linger, Alisa B. Lee-Sherick, Deborah DeRyckere, Rebecca A. Cohen, Kristen M. Jacobsen, Amy McGranahan, Luis N. Brandão, Amanda Winges, Kelly K. Sawczyn, Xiayuan Liang, Amy K. Keating, Aik Choon Tan, H. Shelton Earp, Douglas K. Graham
Journal: Blood
Blood (2013) 122 (9): 1599–1609.
https://doi.org/10.1182/blood-2013-01-478156
Published: 2013
Includes: Supplemental data
Journal Articles

Evaluation of UNC569, a Novel Small Molecule Mer Inhibitor for the Treatment of ALL in Vitro and in Vivo.

Sandra Christoph, Deborah DeRyckere, PhD, Jennifer Schlegel, Susan Sather, BS, Amy McGranahan, J. Kimble Franzer, Alesia Trakhimets, Xiaodong Wang, Dmitri Kireev, William Janzen, Jing Liu, Chao Yang, Catherine Simpson, Jacqueline Norris-Drouin, Stephen Frye, H. Shelton Earp, III, Gary L. Johnson, Douglas K. Graham
Journal: Blood
Blood (2012) 120 (21): 2607.
https://doi.org/10.1182/blood.V120.21.2607.2607
Published: 2012
Journal Articles

Mer Receptor Tyrosine Kinase Is A Potential Therapeutic Target in Acute Myeloid Leukemia

Alisa B. Lee-Sherick, MD, Kelly Menachof, Kristen M. Eisenman, MD, Amy McGranahan, Colleen McGary, Sally A. Hunsucker, PhD, Jennifer Schlegel, Paul M Armistead, MD, PhD, Xiayuan Liang, MD, Dmitri Kireev, William Janzen, Jing Liu, Michael Stashko, Jacqueline Norris-Drouin, H. Shelton Earp, III, Xiaodong Wang, Stephen Frye, Deborah DeRyckere, PhD, Douglas K. Graham, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1317.
https://doi.org/10.1182/blood.V120.21.1317.1317
Published: 2012